Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Debt to Equity (2018 - 2019)

10x Genomics (TXG) has disclosed Debt to Equity for 2 consecutive years, with $0.07 as the latest value for Q4 2019.

  • Quarterly Debt to Equity rose 152.44% to $0.07 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $0.07 through Dec 2019, up 152.44% year-over-year, with the annual reading at $0.07 for FY2019, 152.44% up from the prior year.
  • Debt to Equity hit $0.07 in Q4 2019 for 10x Genomics, roughly flat from $0.07 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.07 in Q4 2019 to a low of -$0.13 in Q4 2018.